Literature DB >> 11114928

Secreted euryarchaeal microhalocins kill hyperthermophilic crenarchaea.

C Haseltine1, T Hill, R Montalvo-Rodriguez, S K Kemper, R F Shand, P Blum.   

Abstract

Few antibiotics targeting members of the archaeal domain are currently available for genetic studies. Since bacterial antibiotics are frequently directed against competing and related organisms, archaea by analogy might produce effective antiarchaeal antibiotics. Peptide antibiotic (halocin) preparations from euryarchaeal halophilic strains S8a, GN101, and TuA4 were found to be toxic for members of the hyperthermophilic crenarchaeal genus Sulfolobus. No toxicity was evident against representative bacteria or eukarya. Halocin S8 (strain S8a) and halocin R1 (strain GN101) preparations were cytostatic, while halocin A4 (strain TuA4) preparations were cytocidal. Subsequent studies focused on the use of halocin A4 preparations and Sulfolobus solfataricus. Strain TuA4 cell lysates were not toxic for S. solfataricus, and protease (but not nuclease) treatment of the halocin A4 preparation inactivated toxicity, indicating that the A4 toxic factor must be a secreted protein. Potassium chloride supplementation of the Sulfolobus assay medium potentiated toxicity, implicating use of a salt-dependent mechanism. The utility of halocin A4 preparations for genetic manipulation of S. solfataricus was assessed through the isolation of UV-induced resistant mutants. The mutants exhibited stable phenotypes and were placed into distinct classes based on their levels of resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11114928      PMCID: PMC94877          DOI: 10.1128/JB.183.1.287-291.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  29 in total

1.  Coordinate transcriptional control in the hyperthermophilic archaeon Sulfolobus solfataricus.

Authors:  C Haseltine; R Montalvo-Rodriguez; E Bini; A Carl; P Blum
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

2.  What archaea have to tell biologists.

Authors:  W B Whitman; F Pfeifer; P Blum; A Klein
Journal:  Genetics       Date:  1999-08       Impact factor: 4.562

Review 3.  Transcriptional regulation in Archaea.

Authors:  J A Leigh
Journal:  Curr Opin Microbiol       Date:  1999-04       Impact factor: 7.934

Review 4.  Peptide antibiotics.

Authors:  R E Hancock; D S Chapple
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 5.  Biology of moderately halophilic aerobic bacteria.

Authors:  A Ventosa; J J Nieto; A Oren
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

6.  Archaeal translation initiation revisited: the initiation factor 2 and eukaryotic initiation factor 2B alpha-beta-delta subunit families.

Authors:  N C Kyrpides; C R Woese
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 7.  Ancient ciphers: translation in Archaea.

Authors:  P P Dennis
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

Review 8.  Bacteriocins: nature, function and structure.

Authors:  M A Daw; F R Falkiner
Journal:  Micron       Date:  1996-12       Impact factor: 2.251

9.  Homologous gene knockout in the archaeon Halobacterium salinarum with ura3 as a counterselectable marker.

Authors:  R F Peck; S DasSarma; M P Krebs
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

Review 10.  Genetics of Methanococcus: possibilities for functional genomics in Archaea.

Authors:  D L Tumbula; W B Whitman
Journal:  Mol Microbiol       Date:  1999-07       Impact factor: 3.501

View more
  9 in total

1.  Growth kinetics of extremely halophilic archaea (family halobacteriaceae) as revealed by arrhenius plots.

Authors:  Jessie L Robinson; Brandy Pyzyna; Rachelle G Atrasz; Christine A Henderson; Kira L Morrill; Anna Mae Burd; Erik Desoucy; Rex E Fogleman; John B Naylor; Sarah M Steele; Dawn R Elliott; Kathryn J Leyva; Richard F Shand
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

2.  The sulfolobicin genes of Sulfolobus acidocaldarius encode novel antimicrobial proteins.

Authors:  Albert F Ellen; Olha V Rohulya; Fabrizia Fusetti; Michaela Wagner; Sonja-Verena Albers; Arnold J M Driessen
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

3.  Isolation, characterization and exploring biotechnological potential of halophilic archaea from salterns of western India.

Authors:  Aparna Singh; Anil Kumar Singh
Journal:  3 Biotech       Date:  2018-01-03       Impact factor: 2.406

4.  A protein important for antimicrobial peptide resistance, YdeI/OmdA, is in the periplasm and interacts with OmpD/NmpC.

Authors:  M Carolina Pilonieta; Kimberly D Erickson; Robert K Ernst; Corrella S Detweiler
Journal:  J Bacteriol       Date:  2009-09-18       Impact factor: 3.490

5.  Purification and biological characterization of halocin C8, a novel peptide antibiotic from Halobacterium strain AS7092.

Authors:  Yun Li; Hua Xiang; Jingfang Liu; Meixian Zhou; Huarong Tan
Journal:  Extremophiles       Date:  2003-06-17       Impact factor: 2.395

6.  Mercury inactivates transcription and the generalized transcription factor TFB in the archaeon Sulfolobus solfataricus.

Authors:  Vidula Dixit; Elisabetta Bini; Melissa Drozda; Paul Blum
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

7.  Diversity and subcellular distribution of archaeal secreted proteins.

Authors:  Zalan Szabo; Mechthild Pohlschroder
Journal:  Front Microbiol       Date:  2012-07-02       Impact factor: 5.640

8.  Purification and Characterization of a New Halocin HA4 from Haloferax larsenii HA4 Isolated from a Salt Lake.

Authors:  Ramanjeet Kaur; Santosh Kumar Tiwari
Journal:  Probiotics Antimicrob Proteins       Date:  2021-07-20       Impact factor: 4.609

Review 9.  Untapped Resources: Biotechnological Potential of Peptides and Secondary Metabolites in Archaea.

Authors:  James C Charlesworth; Brendan P Burns
Journal:  Archaea       Date:  2015-10-04       Impact factor: 3.273

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.